Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

HIV treatment

New NNRTI doravirine suppresses HIV as well as efavirenz but with fewer central nervous system side-effects

News
23 July 2015
Starting treatment

Same-day start to antiretroviral treatment leads to faster HIV suppression in San Francisco

News
23 July 2015
Adherence

Africa: MSF Warns Successful Global HIV Response Will Require Bigger Emphasis On Adherence

Editor's pick
AllAfrica
22 July 2015
HIV treatment

Next-generation maturation inhibitor BMS-955176 shows good antiviral activity in combination with atazanavir

News
22 July 2015
PrEP science

Intermittent PrEP may be a robust strategy for anal sex – vaginal much less certain

News
22 July 2015
Access to healthcare

IAS 2015: While “game-changing,” START trial draws “line in the sand” and sets “time a’ ticking” to stop preventable illnesses and death, calls for action are accompanied by questions of impact of inequities, obstacles

Editor's pick
Science Speaks
21 July 2015
Starting treatment

START trial provides definitive evidence of the benefits of early HIV treatment

News
21 July 2015
PrEP science

Non-daily PrEP regimens provide extra options, but adherence is often better with daily dosing

News
21 July 2015
The search for a cure

Targets proliferate in HIV cure research

News
21 July 2015
The search for a cure

Young woman stays undetectable for twelve years off treatment after early HIV therapy

News
21 July 2015
HIV treatment

European Commission Approves Bristol-Myers Squibb’s Evotaz (atazanavir and cobicistat fixed-dose combination) for the Treatment of HIV-1 Infection in Adults

Editor's pick
BMS press release
20 July 2015
Treatment guidelines

World Health Organization to recommend HIV treatment for all

News
20 July 2015
HIV treatment

Reaching UNAIDS HIV treatment targets could avert millions of deaths and new infections

News
18 July 2015
The search for a cure

New drug holds out promise of long-term control or even cure of HIV

News
18 July 2015
Pharmaceutical industry

TAG Pipeline Report

Editor's pick
TAG
17 July 2015
New & experimental HIV treatments

Evidence of HIV Suppression With PRO 140 Monotherapy Reaching Nearly 11 Months

Editor's pick
CytoDyn press release
16 July 2015
Changing treatment

HIV-positive patients in Africa do well on three second-line ART regimens

News
16 July 2015
Access to healthcare

People with HIV live almost 20 years longer than in 2001

Editor's pick
The Guardian
14 July 2015
Access to healthcare

UNAIDS announces that the goal of 15 million people on life-saving HIV treatment by 2015 has been met nine months ahead of schedule

Editor's pick
UNAIDS
14 July 2015
Adherence

Second-line ART patients reach viral re-suppression following intensified adherence support

News
13 July 2015
PrEP science

Black market for Truvada PrEP may undermine treatment adherence in marginalised people living with HIV

News
13 July 2015
New & experimental HIV treatments

Scripps Research Institute-Designed Drug Candidate Significantly Reduces HIV Reactivation Rate

Editor's pick
Scripps Research Institute
11 July 2015
Retention & linkage to care

Community-based adherence clubs show high retention in HIV care and treatment adherence

News
10 July 2015
Starting treatment

Prompt ART especially important for people with HIV aged 45 and over

News
8 July 2015